Literature DB >> 2026451

Characterization of the major neutrophil-stimulating activity present in culture medium conditioned by Staphylococcus aureus-stimulated mononuclear leucocytes.

E J Bates1, A Ferrante, L J Beard.   

Abstract

Culture medium conditioned by stimulating human mononuclear leucocytes (MNL) with killed Staphylococcus aureus (Scm) was found to contain a substantial amount of tumour necrosis factor-alpha (TNF-alpha) but no detectable tumour necrosis factor-beta (TNF-beta). Culture medium conditioned by MNL in the absence of bacteria contained no TNF-alpha activity. When Scm was fractionated by high-performance liquid chromatography (HPLC) on Bio-Sil TSK 250, TNF-alpha co-eluted with neutrophil-stimulating activity measured by chemiluminescence. Similarly, the ability of neutrophils to kill opsonized S. aureus was enhanced in fractions that contained this neutrophil-stimulating activity. The stimulating activity could be almost completely removed by pretreatment of the Scm with a TNF-alpha-specific monoclonal antibody (mAb). The ability of neutrophils to kill S. aureus in response to Scm was also substantially reduced by mAb to TNF-alpha. These results demonstrate that bacterial interaction with MNL leads to the release of neutrophil-stimulating activity that consists predominantly of TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026451      PMCID: PMC1384410     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  Regulation of neutrophil migration and superoxide production by recombinant tumor necrosis factors-alpha and -beta: comparison to recombinant interferon-gamma and interleukin-1 alpha.

Authors:  I S Figari; N A Mori; M A Palladino
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

2.  Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor.

Authors:  B Perussia; M Kobayashi; M E Rossi; I Anegon; G Trinchieri
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

3.  Separation of mononuclear and polymorphonuclear leucocytes from human blood by the one-step Hypaque-Ficoll method is dependent on blood column height.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

4.  Stimulation of neutrophils by tumor necrosis factor.

Authors:  S J Klebanoff; M A Vadas; J M Harlan; L H Sparks; J R Gamble; J M Agosti; A M Waltersdorph
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

5.  Production of tumor necrosis factors alpha and beta by human mononuclear leukocytes stimulated with mitogens, bacteria, and malarial parasites.

Authors:  A Ferrante; R E Staugas; B Rowan-Kelly; S Bresatz; L M Kumaratilake; C M Rzepczyk; G R Adolf
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

6.  Suppression of human monocyte interleukin 1 production by the plant alkaloid tetrandrine.

Authors:  W K Seow; A Ferrante; S Y Li; Y H Thong
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

7.  Stimulation of human neutrophil degranulation by mefloquine.

Authors:  E J Bates; A Ferrante
Journal:  Int Arch Allergy Appl Immunol       Date:  1988

8.  Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.

Authors:  M R Shalaby; B B Aggarwal; E Rinderknecht; L P Svedersky; B S Finkle; M A Palladino
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

9.  Neutrophil stimulating activity released by Staphylococcus-stimulated mononuclear leukocyte conditioned medium. Further characterization and partial purification.

Authors:  A Ferrante; E J Bates; M Nandoskar
Journal:  J Chromatogr       Date:  1988-05-25

10.  Staphylococcus aureus-stimulated human mononuclear leucocyte-conditioned medium augments the basal and stimuli-induced neutrophil respiratory burst and degranulation.

Authors:  A Ferrante; M Nandoskar; E J Bates; D H Goh
Journal:  Immunology       Date:  1987-03       Impact factor: 7.397

View more
  6 in total

1.  Staphylococcus aureus SaeR/S-Regulated Factors Decrease Monocyte-Derived Tumor Necrosis Factor-α to Reduce Neutrophil Bactericidal Activity.

Authors:  Eli W Sward; Elizabeth M Fones; Russel R Spaan; Kyler B Pallister; Brandon L Haller; Fermin E Guerra; Oliwia W Zurek; Tyler K Nygaard; Jovanka M Voyich
Journal:  J Infect Dis       Date:  2018-03-05       Impact factor: 5.226

2.  Differential effects of small tumour necrosis factor-alpha peptides on tumour cell cytotoxicity, neutrophil activation and endothelial cell procoagulant activity.

Authors:  D A Rathjen; A Ferrante; R Aston
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

3.  Vaccine display on artificial bacterial spores enhances protective efficacy against Staphylococcus aureus infection.

Authors:  Hatice Karauzum; Taylor B Updegrove; Minsuk Kong; I-Lin Wu; Sandip K Datta; Kumaran S Ramamurthi
Journal:  FEMS Microbiol Lett       Date:  2018-09-01       Impact factor: 2.742

Review 4.  Epic Immune Battles of History: Neutrophils vs. Staphylococcus aureus.

Authors:  Fermin E Guerra; Timothy R Borgogna; Delisha M Patel; Eli W Sward; Jovanka M Voyich
Journal:  Front Cell Infect Microbiol       Date:  2017-06-30       Impact factor: 5.293

5.  Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus.

Authors:  Lei Shi; Kazue Takahashi; Joseph Dundee; Sarit Shahroor-Karni; Steffen Thiel; Jens Christian Jensenius; Faten Gad; Michael R Hamblin; Kedarnath N Sastry; R Alan B Ezekowitz
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

6.  Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation.

Authors:  Violet R Mukaro; Alex Quach; Michelle E Gahan; Bernadette Boog; Zhi H Huang; Xiuhui Gao; Carol Haddad; Suresh Mahalingam; Charles S Hii; Antonio Ferrante
Journal:  Nat Commun       Date:  2018-04-10       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.